S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10
S&P 500   4,158.24
DOW   33,212.96
QQQ   309.10

Cello Health plc (CLL.L) (CLL) Share Forecast, Price & News

GBX 161
0.00 (0.00%)
(As of 08/11/2020)
Today's Range
50-Day Range
52-Week Range
Average Volume
453,244 shs
Market Capitalization
£178.84 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive CLL News and Ratings via Email

Sign-up to receive the latest news and ratings for Cello Health plc (CLL.L) and its competitors with MarketBeat's FREE daily newsletter.

Cello Health plc (CLL.L) logo

About Cello Health plc (CLL.L)

Cello Health plc, together with its subsidiaries, provides marketing services in the United Kingdom, Rest of Europe, the United States, and internationally. It operates in two segments, Cello Health and Cello Signal. The Cello Health segment offers market research, consulting, and communications services principally to the pharmaceutical and healthcare clients. The Cello Signal segment provides market research and direct communications services principally to consumer-facing clients. Cello Health plc was incorporated in 2004 and is headquartered in London, the United Kingdom.


See More Headlines

Industry, Sector and Symbol

Marketing Services
Year Founded

Sales & Book Value

Annual Sales
£166.77 million
Cash Flow
GBX 8 per share
Book Value
GBX 77.60 per share


Pretax Margin




Free Float
Market Cap
£178.84 million
Not Optionable


Overall MarketRank

1.17 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Cello Health plc (CLL.L) (LON:CLL) Frequently Asked Questions

Is Cello Health plc (CLL.L) a good dividend stock?

Cello Health plc (CLL.L) pays an annual dividend of GBX 2 per share and currently has a dividend yield of 1.34%.
View Cello Health plc (CLL.L)'s dividend history.

Who are Cello Health plc (CLL.L)'s key executives?
Cello Health plc (CLL.L)'s management team includes the following people:
  • Mr. Mark Scott, CEO & Exec. Director (Age 53)
  • Mr. Mark Bentley, Group Fin. Director, Company Sec. & Exec. Director (Age 48)
  • Mr. Stephen Highley, Group COO & Director
  • Mr. Owen Williams, Managing Partner
  • Mr. Vincent Nolan, Managing Partner
What other stocks do shareholders of Cello Health plc (CLL.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cello Health plc (CLL.L) investors own include Lloyds Banking Group (LLOY), Sirius Minerals (SXX), Saga (SAGA), QinetiQ Group (QQ), (OPTR) (OPTR), Modern Water plc (MWG.L) (MWG), IGas Energy (IGAS), 1984318 (IAP.L) (IAP), Gilead Sciences (GILD) and easyJet (EZJ).

What is Cello Health plc (CLL.L)'s stock symbol?

Cello Health plc (CLL.L) trades on the London Stock Exchange (LON) under the ticker symbol "CLL."

How do I buy shares of Cello Health plc (CLL.L)?

Shares of CLL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Cello Health plc (CLL.L)'s stock price today?

One share of CLL stock can currently be purchased for approximately GBX 161.

How much money does Cello Health plc (CLL.L) make?

Cello Health plc (CLL.L) has a market capitalization of £178.84 million and generates £166.77 million in revenue each year.

What is Cello Health plc (CLL.L)'s official website?

The official website for Cello Health plc (CLL.L) is www.cellogroup.com.

How can I contact Cello Health plc (CLL.L)?

Cello Health plc (CLL.L)'s mailing address is 11-13 Charterhouse Buildings, LONDON, EC1M 7AP, United Kingdom. The company can be reached via phone at +44-20-78128460.

This page was last updated on 5/28/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.